National Asset Management Inc. bought a new position in shares of Cano Health, Inc. (NYSE:CANO – Get Rating) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 14,000 shares of the company’s stock, valued at approximately $89,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Gleason Group Inc. bought a new position in Cano Health during the first quarter worth about $41,000. Mirabella Financial Services LLP bought a new position in Cano Health during the fourth quarter worth about $90,000. Pictet Asset Management SA bought a new position in Cano Health during the fourth quarter worth about $94,000. Ensign Peak Advisors Inc bought a new position in Cano Health during the fourth quarter worth about $103,000. Finally, GSA Capital Partners LLP boosted its position in Cano Health by 21.7% during the fourth quarter. GSA Capital Partners LLP now owns 12,913 shares of the company’s stock worth $115,000 after purchasing an additional 2,302 shares during the period. Institutional investors own 37.64% of the company’s stock.
Cano Health Trading Up 0.8 %
Shares of CANO opened at $6.14 on Tuesday. The firm’s 50 day simple moving average is $5.38 and its 200 day simple moving average is $5.62. The company has a market capitalization of $2.97 billion, a P/E ratio of -21.93 and a beta of 1.64. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.04 and a quick ratio of 2.04. Cano Health, Inc. has a 1-year low of $3.81 and a 1-year high of $15.58.
Analyst Ratings Changes
A number of brokerages have weighed in on CANO. Citigroup cut their target price on shares of Cano Health from $10.00 to $8.00 in a research report on Tuesday, May 10th. Cowen lowered their price target on shares of Cano Health from $13.00 to $10.00 in a report on Tuesday, May 10th. Raymond James began coverage on shares of Cano Health in a report on Friday, June 24th. They issued an “outperform” rating and a $8.00 price target on the stock. UBS Group lowered their price target on shares of Cano Health to $14.00 and set a “na” rating on the stock in a report on Tuesday, May 17th. Finally, Bank of America downgraded shares of Cano Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $8.00 to $6.00 in a report on Wednesday, June 15th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $10.90.
About Cano Health
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
- Get a free copy of the StockNews.com research report on Cano Health (CANO)
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- The Colgate-Palmolive Growth Outlook Brightens
- Deep Value High Yield Newell Brands Is Ready To Bottom
- These Stocks Outperformed Last Time There Was A Recession
- Does Rivian’s Stock Still Have A Future?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.